Plunkett Research Online: HOOKIPA Pharma Inc

HOOKIPA PHARMA INC (HOOK:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

HOOKIPA Pharma, Inc. is a clinical-stage biopharmaceutical company developing a new class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform, which is designed to reprogram the body’s immune system. HOOKIPA’s technology is capable of reprogr.....



HOOKIPA Pharma Inc
Ticker: HOOK
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 431 890-6360
Fax:
Address: 350 Fifth Avenue
72nd Floor, Suite 7240
New York, NY 10118 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceutical Preparation Manufacturing
Biophamraceuticals
Clinical Trials
Drug Development
Immuno Therapeutics
Infectious Disease Therapies
Cancer Therapies
Contacts Description

Jorn Aldag CEO/Director
Reinhard Kandera CFO/Director
See More
HOOKIPA Pharma, Inc. is a clinical-stage biopharmaceutical company developing a new class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform, which is designed to reprogram the body’s immune system. HOOKIPA’s technology is capable of reprogr.....See More See More

Auditor: PwC Wirtschaftsprufung GmbH
Legal Advisor:
$USD, In whole numbers,
except marked * or %
2020 2019 2018 2017
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: